Scribd Logo
Upload

Welcome to Scribd!

  • NURS 1566 Clinical Form 3: Clinical Medications Worksheets: Medical Patients With Acute Illness - 40 MG Once Daily

    Uploaded by

    Katie McPeek
    28 views3 pages
    The document provides information on the generic and trade names, classification, dosing, administration, and timing of the drug Enoxaparin (Lovenox) which is used to prevent deep vein thrombosis and pulmonary embolism. It also lists the drug's mechanism of action, indications, contraindications, warnings, interactions, and important nursing considerations like monitoring for bleeding and checking lab values. The nursing process section covers pre-administration assessment of signs of bleeding, when to hold the medication, and what to evaluate after administration.

    Original Description:

    Original Title

    Lo en Ox

    Copyright

    © Attribution Non-Commercial (BY-NC)

    Available Formats

    DOC, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    The document provides information on the generic and trade names, classification, dosing, administration, and timing of the drug Enoxaparin (Lovenox) which is used to prevent deep vein thrombosis and pulmonary embolism. It also lists the drug's mechanism of action, indications, contraindications, warnings, interactions, and important nursing considerations like monitoring for bleeding and checking lab values. The nursing process section covers pre-administration assessment of signs of bleeding, when to hold the medication, and what to evaluate after administration.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as DOC, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    28 views3 pages

    NURS 1566 Clinical Form 3: Clinical Medications Worksheets: Medical Patients With Acute Illness - 40 MG Once Daily

    Uploaded by

    Katie McPeek
    The document provides information on the generic and trade names, classification, dosing, administration, and timing of the drug Enoxaparin (Lovenox) which is used to prevent deep vein thrombosis and pulmonary embolism. It also lists the drug's mechanism of action, indications, contraindications, warnings, interactions, and important nursing considerations like monitoring for bleeding and checking lab values. The nursing process section covers pre-administration assessment of signs of bleeding, when to hold the medication, and what to evaluate after administration.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as DOC, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    of 3

    NURS 1566 Clinical Form 3: Clinical Medications Worksheets

    (You will need to make additional copies of these forms)

    Generic Name Trade Name Classification Dose Route Time/frequency


    Enoxaparin Lovenox Low molecular 40 mg SQ Daily
    weight heparins
    Peak Onset Duration Normal dosage range
    Unknown Unknown 12 hrs Medical patients with acute illness--40 mg once daily

    Why is your patient getting this medication For IV meds, compatibility with IV drips and/or solutions
    Prevention of DVT/Pulmonary Embolism N/A
    Mechanism of action and indications Nursing Implications (what to focus on)
    (Why med ordered) Contraindications/warnings/interactions
    Potentiates the inhibitory effect of antithrombin on factor Xa . Contraindicated in:
    and thrombin. Indicated for prevention and treatment of DVT •
    and Pulmonary Embolism H
    yper
    sens
    itivi
    ty

    •
    H
    yper
    sens
    itivi
    ty to
    ben
    zyl
    alco
    hol
    (mu
    ltido
    se
    vial)

    •
    Posi
    tive
    in
    vitr
    o
    test
    for
    anti
    plat
    elet
    anti
    bod
    y in
    the
    pres
    ence
    of
    eno
    xap
    arin

    •
    Acti
    ve,
    maj
    or

    Use Cautiously in:


    Interactions with other patient drugs, OTC or herbal Lab value alterations caused by medicine
    medicines (ask patient specifically) Monitor CBC, platelet count, and stools for occult blood periodically
    None for this patient during therapy. If thrombocytopenia occurs, monitor closely. If
    hematocrit decreases unexpectedly, assess patient for potential bleeding
    sites
    Be sure to teach the patient the following about this
    medication
    Advise patient to report any symptoms of unusual bleeding or bruising,
    dizziness, itching, rash, fever, swelling, or difficulty breathing to health
    care professional immediately
    Nursing Process- Assessment Assessment Evaluation
    (Pre-administration assessment) Why would you hold or not give this Check after giving
    Assess for abnormal bleeding and monitor med? Signs of bleeding and
    aPTT. Assess for signs of bleeding and If signs of bleeding and hemorrhage hemorrhage and aPTT levels.
    hemorrhage (bleeding gums; nosebleed; unusual are present.
    bruising; black, tarry stools; hematuria; fall in
    hematocrit or blood pressure; guaiac-positive
    stools); bleeding from surgical site. Notify
    physician or other health care professional if these
    occur

    You might also like